HOME     |     LANGUAGE/COUNTRY     |     SHOP


Search  

Semex News

NEOGEN® AND SEMEX® PARTNER TO DELIVER SEMEX’S IMMUNITY TECHNOLOGY FOR HEALTHIER HERDS
Neogen Corporation and Semex announced today their partnership to deliver Semex’s Immunity Te...
SEMEX ANNOUNCES RYAN LETT SUCCEEDS DAVID MAYO AT SEMEX NEW ZEALAND
Semex is pleased to announce that Ryan Lett will succeed David Mayo as General Manager of Semex N...
BOVITEQ ANNOUNCES NEW LAB & SATELLITE AT ARIZONA DAIRY COMPANY
Boviteq is thrilled to announce opening a cutting-edge OPU (Oocyte Pick-Up) satellite facility and ...
SEMEX 2025-2026 BOARD OF DIRECTORS ANNOUNCED
Semex is pleased to announce its 2025-2026 Board of Directors. Jean-François Morin (CIAQ) wi...
BOVITEQ ANNOUNCES NEW LICENSEE IN JAPAN
Boviteq is pleased to announce that Nosawa, a longstanding partner of Semex for over 40 years, will...
BOVITEQ ANNOUNCES BLUE BOX LAB IN AUSTRALIA
Boviteq is excited to announce the installation of the Boviteq Blue Box™ in Australia! This a...

View All Articles
BOVITEQ ANNOUNCES NEW LICENSEE SERVING SPAIN & PORTUGAL
Article posted on August 22, 2024, 16:55:33

Boviteq is thrilled to announce the strategic selection of a new licensee location in Spain. This new IVF partner will combine its local intelligence with Boviteq knowledge to deliver the industry’s leading IVF services to clients.



Now, clients in Spain and Portugal through Embriovet have access to Boviteq’s excellent products and services, promising a brighter future for the industry.



“With the growth in IVF services and the extreme demand for our product worldwide, we seek partners to work shoulder-to-shoulder with bovine producers.  Embriovet is a logical choice,” says Melissa Bowers, Semex Vice President, Embryo Division. “Embriovet and Dr. Daniel Bello share our values of excellent service and client relationships along with an embryo philosophy that meshes with our own, making them ideal partners.”



"We are very excited to be partners with Boviteq,” says Dr. Bello. “We have worked in the embryo world for 30 years and always seek excellence. With Boviteq, we take a qualitative leap by incorporating the most advanced technology and accessing the knowledge and experience accumulated by one of the most prestigious groups recognized worldwide. Our clients make significant efforts and investments in genetic improvement and deserve that we support them with the best tools at our disposal. Improving the production of high-quality in vitro embryos with proven freezing technology that facilitates direct transfer will rejuvenate the domestic and export markets, giving us a solid base from which to grow.”




Print this Article | Email this Article